Amila Siriwardana

6PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Evolutionary computationMedical infection agents (incl. prions)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 24, 2025
A prospective, multi-centre trial of PSMA-PET compared to FDG-PET for staging of newly diagnosed high risk prostate cancer.

Matthew J Roberts, Natasha A Roberts, Anita Pelecanos

|May 23, 2025
Simultaneous robotic-assisted prostatectomy and rectal resection: a systematic review.

Harry Collin, Benjamin Huang, Amila Siriwardana

|Jan 29, 2025
Improving clinical efficiency using retrieval-augmented generation in urologic oncology: A guideline-enhanced artificial intelligence approach.

Harry Collin, Matthew J Roberts, Kandice Keogh

|Jul 10, 2019
Diagnostic accuracy of <sup>68</sup> Ga-prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) and multiparametric (mp)MRI to detect intermediate-grade intra-prostatic prostate cancer using whole-mount pathology: impact of the addition of <sup>68</sup> Ga-PSMA PET to mpMRI.

Matthijs J Scheltema, John I Chang, Phillip D Stricker

|Aug 11, 2017
Focal irreversible electroporation as primary treatment for localized prostate cancer.

Willemien van den Bos, Matthijs J Scheltema, Amila R Siriwardana

|May 27, 2017
Initial multicentre experience of <sup>68</sup> gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited.

Amila Siriwardana, James Thompson, Pim J van Leeuwen

Pageof 1

Frequent Collaborators

3 joint publications

Matthew J Roberts

2 joint publications

Matthijs J Scheltema

2 joint publications

Harry Collin

1 joint publications

Willemien van den Bos